Literature DB >> 8666905

Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease.

L Biancone1, G Andres, H Ahn, A Lim, C Dai, R Noelle, H Yagita, C De Martino, I Stamenkovic.   

Abstract

We assessed the role of CD40-CD40L, cytotoxic T lymphocyte (CTL)A4/CD28-B7s, and CD2-CD48/CD58 lymphocyte costimulatory pathways in the development of mercury chloride (HgCl2)-induced autoimmune disease in mice, which is believed to be mediated by T helper (Th) subset Th2. Inhibition of CD40-CD40-L and CTLA4/CD28-B7s interactions by anti-CD40-L antibody and soluble CTLA4-immunoglobulin (Ig) fusion protein, respectively, abrogated the autoimmune disease without affecting interleukin 4 (IL-4) production, showing the importance of physical contact between T and B lymphocytes in the Th2-mediated process. In contrast, two anti-CD2 antibodies that have been shown to induce immunosuppression of Th1-mediated events exacerbated the autoantibody response and augmented IgG1, IgE, and IL-4 production, transforming a mild mesangial glomerulopathy into a severe systemic immune complex disease. These observations demonstrate that manipulation of lymphocyte accessory counterreceptor interactions may affect the course of Th2-associated autoimmune disease and suggest that signals resulting from CD2 engagement play an essential role in the regulation of the Th1-Th2 effector equilibrium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666905      PMCID: PMC2192532          DOI: 10.1084/jem.183.4.1473

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies.

Authors:  K D Chavin; H T Lau; J S Bromberg
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

2.  Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells.

Authors:  M de Boer; A Kasran; J Kwekkeboom; H Walter; P Vandenberghe; J L Ceuppens
Journal:  Eur J Immunol       Date:  1993-12       Impact factor: 5.532

3.  Analysis of IL-2, IL-4, and IFN-gamma-producing cells in situ during immune responses to protein antigens.

Authors:  S A Bogen; I Fogelman; A K Abbas
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

4.  TCR-dependent and -independent signaling mechanisms differentially regulate lymphokine gene expression in the murine T helper clone D10.G4.1.

Authors:  H Naora; J G Altin; I G Young
Journal:  J Immunol       Date:  1994-06-15       Impact factor: 5.422

5.  Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.

Authors:  P S Linsley; P M Wallace; J Johnson; M G Gibson; J L Greene; J A Ledbetter; C Singh; M A Tepper
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

6.  Anti-CD2 mAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockade.

Authors:  K D Chavin; L Qin; R Yon; J Lin; H Yagita; J S Bromberg
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

7.  Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.

Authors:  L Qin; K D Chavin; J Lin; H Yagita; J S Bromberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

8.  CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.

Authors:  K Kato; M Koyanagi; H Okada; T Takanashi; Y W Wong; A F Williams; K Okumura; H Yagita
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

9.  Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.

Authors:  K Nishikawa; Y J Guo; M Miyasaka; T Tamatani; A B Collins; M S Sy; R T McCluskey; G Andres
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

10.  CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4.

Authors:  J G McArthur; D H Raulet
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  13 in total

1.  Pretreatment of lymphocytes with mercury in vitro induces a response in T cells from genetically determined low-responders and a shift of the interleukin profile.

Authors:  H Hu; M Abedi-Valugerdi; G Möller
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 2.  Mercury-induced inflammation and autoimmunity.

Authors:  K Michael Pollard; David M Cauvi; Christopher B Toomey; Per Hultman; Dwight H Kono
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-02-10       Impact factor: 3.770

3.  Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice.

Authors:  M Abedi-Valugerdi; C Nilsson; A Zargari; F Gharibdoost; J W DePierre; M Hassan
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity.

Authors:  L M Bagenstose; R Class; P Salgame; M Monestier
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.

Authors:  K Michael Pollard; Gabriela M Escalante; Hua Huang; Katarina M Haraldsson; Per Hultman; Joseph M Christy; Rahul D Pawar; Jessica M Mayeux; Rosana Gonzalez-Quintial; Roberto Baccala; Bruce Beutler; Argyrios N Theofilopoulos; Dwight H Kono
Journal:  J Immunol       Date:  2017-10-20       Impact factor: 5.422

6.  Depletion of complement does not impact initiation of xenobiotic-induced autoimmune disease.

Authors:  David M Cauvi; Christopher B Toomey; K Michael Pollard
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

7.  Genetics of graft-versus-host disease, I. A locus on chromosome 1 influences development of acute graft-versus-host disease in a major histocompatibility complex mismatched murine model.

Authors:  R D Allen; J A Dobkins; J M Harper; D L Slayback
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

8.  Gold- and silver-induced murine autoimmunity--requirement for cytokines and CD28 in murine heavy metal-induced autoimmunity.

Authors:  S Havarinasab; K M Pollard; P Hultman
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

Review 9.  The role of costimulatory molecules in allergic disease and asthma.

Authors:  Vincent Lombardi; Abinav K Singh; Omid Akbari
Journal:  Int Arch Allergy Immunol       Date:  2009-09-29       Impact factor: 2.749

Review 10.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.